LogicBio Therapeutics is based in Cambridge, MA. It has raised $50M in total funding.
LogicBio Therapeutics funding overview
LogicBio Therapeutics is based in Cambridge, MA. LogicBio Therapeutics has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. The round record for LogicBio Therapeutics runs through 2017; nothing later has been disclosed. Investors on record include Arix Biosciences, OrbiMed, Edmond de Rothschild Investment Partners, Pontifax, SBI Japan-Israel Innovation Fund. 5 distinct backers are named across the disclosed rounds.
LogicBio Therapeutics at a glance
Total raised
$50M
Latest round date
June 2017
Headquarters
Cambridge, MA
Notable investors
Arix Biosciences, OrbiMed, Edmond de Rothschild Investment Partners, Pontifax, SBI Japan-Israel Innovation Fund
Frequently asked about LogicBio Therapeutics funding
How much has LogicBio Therapeutics raised?
LogicBio Therapeutics has raised $50M in total disclosed funding across the rounds on record.
Who has invested in LogicBio Therapeutics?
Arix Biosciences, OrbiMed, Edmond de Rothschild Investment Partners, Pontifax, SBI Japan-Israel Innovation Fund are named among the investors backing LogicBio Therapeutics.
What was the latest LogicBio Therapeutics funding round?
No round stage has been disclosed for LogicBio Therapeutics.
Where is LogicBio Therapeutics based?
LogicBio Therapeutics is based in Cambridge, MA.
When did LogicBio Therapeutics last raise?
The last disclosed LogicBio Therapeutics round closed in June 2017.
We update the LogicBio Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Cambridge and their backers are listed below.
